EDGAR Filing Documents for 0001213900-15-009538

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001213900-15-009538

Filing Date

2015-12-17

Accepted

2015-12-17 09:38:04

Documents

Period of Report

2015-12-15

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	f4121515seth2_relmada.html	4
1	OWNERSHIP DOCUMENT	f4121515seth2_relmada.xml	4	8973
	Complete submission text file	0001213900-15-009538.txt		10407

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036

Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 E 93RD STREET, #20-B NEW YORK NY 10128

Business Address

Type: 4 | Act: 34 | File No.: 000-55347 | Film No.: 151292429